The National Health Surveillance Agency (Anvisa) determined on Thursday (23) the ban and recall of batches of the drug losartan, used to treat hypertension and heart failure. The active ingredient is one of the most used against these diseases in Brazil.
According to the Agency, the measure was taken “due to the presence of the ‘azido’ impurity in a concentration above the acceptable safety limit”.
Patients using the drug should not discontinue treatment. , informed Anvisa, since the measure is preventive. “Failing to take the drug can bring more risks to the patient’s health,” the agency said.
Even if the drug is from one of the affected batches, the Agency recommends the continuity of treatment and communication with the doctor responsible for the orientation and indication of losartan.
in this link, Anvisa made available a list with the pharmaceutical companies and the respective batches of the active ingredient that must be collected. The maximum period for completing the collection of these products is up to 120 days.
Source: CNN Brasil
I’m Susan Karen, a professional writer and editor at World Stock Market. I specialize in Entertainment news, writing stories that keep readers informed on all the latest developments in the industry. With over five years of experience in creating engaging content and copywriting for various media outlets, I have grown to become an invaluable asset to any team.
.jpeg "Nature holidays: on a sailing boat to the Pontine Islands with WWF experts")
.jpg "Megan Fox and “compartmentalization”, the self-defense mechanism that was triggered after suffering violence")